StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / galecto.com

Galecto

Galecto (galecto.com): 1 change recorded in its website history since April 2012. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 8 April 2012

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Galecto Biotech

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen November 2026 · 1 capture · latest observed messagingRedefining care for people with blood disorders

    Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
  2. April 2012 – January 2026 · 5 capturesGalecto, Inc. – The leading developer of galectin and ENL-YEATS / FLT3 modulators for the treatment of severe diseases

    This wording observed 16 January 2026.

    archived page
    Inspect 5 captures in this group
    • 8 April 2012 · Galecto Biotech archived page
    • 17 May 2014 · Galecto Biotech | archived page
    • 4 March 2015 · Galecto Biotech | archived page
    • 17 February 2017 · Galecto Biotech | archived page
    • 16 January 2026 · Galecto, Inc. – The leading developer of galectin and ENL-YEATS / FLT3 modulators for the treatment of severe diseases archived page

Cite this record

StartupHistory, “Galecto” company record, https://startuphistory.org/c/galecto.com

Machine-readable: /c/galecto.com.json. How changes are found: method.